Wu Stephan J, Downing Tacy, Mascio Christopher, Gillespie Matthew J, Dori Yoav, Rome Jonathan J, Glatz Andrew C
Division of Cardiology, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, 6th Floor Main Building, 34th Street and Civic Center Boulevard, Philadelphia, PA, 19104, USA.
Nicklaus Children's Hospital, Miami, FL, USA.
Pediatr Cardiol. 2018 Feb;39(2):390-397. doi: 10.1007/s00246-017-1767-6. Epub 2017 Nov 2.
Children requiring reimplantation of a branch pulmonary artery (PA) are at risk for postoperative stenosis and impaired growth of the reimplanted PA. Outcomes and risk factors for reintervention and impaired growth are incompletely described. We reviewed data on patients who underwent reimplantation of a branch PA between 1/1/99 and 5/1/15 at a single center. The primary outcome was reintervention to treat postoperative stenosis. The secondary outcome was "catch-up" growth (faster diameter growth of the affected PA compared with the unaffected PA from the preoperative to follow-up measurements.). Twenty-six patients were identified with a total follow-up of 102.2 patient-years (median 2.5 years). Diagnoses included LPA sling (n = 12) and isolated PA of ductal origin with (n = 7) or without (n = 7) tetralogy of Fallot (ToF). All had primary repair of the anomalous PA. Seventeen (65%) had reintervention with median time to first reintervention of 69 (range 1-1005) days and median of 1.5 (range 1-6) reinterventions. 94% of reinterventions were transcatheter (53% balloon and 41% stent angioplasty). Patients with reintervention were younger (hazard ratio 0.75 per log-day, p = 0.02) and lower weight (hazard ratio 0.18 per log-kg, p = 0.02) at initial repair. Of the 18 with PA growth data, 8 (44%) had catch-up growth. There were no identified differences between those who did and did not demonstrate catch-up growth. Despite a practice of primary reimplantation and aggressive postoperative reintervention, these results suggest that changes in strategy are needed or that there are intrinsic patient factors that have more influence on longer-term reimplanted PA growth.
需要重新植入肺动脉分支(PA)的儿童术后有发生狭窄以及重新植入的PA生长受损的风险。关于再次干预和生长受损的结果及风险因素的描述并不完整。我们回顾了1999年1月1日至2015年5月1日期间在单一中心接受肺动脉分支重新植入手术的患者数据。主要结局是为治疗术后狭窄而进行的再次干预。次要结局是“追赶性”生长(从术前测量到随访测量期间,患侧PA直径增长速度快于未患侧PA)。共确定了26例患者,总随访时间为102.2患者年(中位数2.5年)。诊断包括左肺动脉吊带(n = 12)以及导管起源的孤立性PA,伴有(n = 7)或不伴有(n = 7)法洛四联症(ToF)。所有患者均对异常PA进行了一期修复。17例(65%)接受了再次干预,首次再次干预的中位时间为69天(范围1 - 1005天),再次干预的中位数为1.5次(范围1 - 6次)。94%的再次干预是经导管进行的(53%为球囊扩张,41%为支架血管成形术)。接受再次干预的患者在初次修复时年龄更小(每对数天的风险比为0.75,p = 0.02)且体重更低(每对数千克的风险比为0.18,p = 0.02)。在有PA生长数据的18例患者中,8例(44%)有追赶性生长。在有和没有表现出追赶性生长的患者之间未发现差异。尽管采取了一期重新植入和积极的术后再次干预措施,但这些结果表明,需要改变策略,或者存在对重新植入的PA长期生长有更大影响的内在患者因素。